New York, NY, United States of America

Liad Yamin

This inventor holds 1 USPTO granted patent. Top assignee: Predictably Human, Inc.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liad Yamin: Innovator in Drug Delivery Systems

Introduction

Liad Yamin is a notable inventor based in New York, NY (US), recognized for his contributions to drug delivery systems. He holds a patent that focuses on innovative methods and devices aimed at enhancing treatment programs, particularly in smoking cessation.

Latest Patents

Liad Yamin's patent, titled "Drug delivery systems, devices, and methods," introduces an electronic drug delivery system designed for use in treatment programs. This system includes a mobile platform and a hand-held inhalation delivery device equipped with a controller circuit, power source, sensors, aerosolizer drivers, and a rescue button. The system generates an aerosol mixture from substances in a pod, tailored to the user's treatment program. The controller circuit dynamically controls the aerosolizer drivers to create individually tailored aerosol mixtures, allowing for various percentages of substances and different aerosol droplet sizes throughout the treatment process. He has 1 patent to his name.

Career Highlights

Liad Yamin is currently associated with Predictably Human, Inc., where he continues to innovate in the field of drug delivery. His work focuses on creating systems that improve the efficacy of treatment programs through advanced technology.

Collaborations

Liad has collaborated with notable professionals in his field, including Robert Francis Jacobs, Jr. and J. Robert Geiman. These collaborations have contributed to the development of his innovative drug delivery systems.

Conclusion

Liad Yamin stands out as an inventor dedicated to improving drug delivery methods through technology. His work has the potential to significantly impact treatment programs, particularly for smoking cessation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…